Bicara Therapeutics Stock Forecast - 8 Period Moving Average
| BCAX Stock | 17.53 0.10 0.57% |
The 8 Period Moving Average forecasted value of Bicara Therapeutics Common on the next trading day is expected to be 16.91 with a mean absolute deviation of 0.87 and the sum of the absolute errors of 46.21. Bicara Stock Forecast is based on your current time horizon.
At this time the rsi of Bicara Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Bicara Therapeutics hype-based prediction, you can estimate the value of Bicara Therapeutics Common from the perspective of Bicara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The 8 Period Moving Average forecasted value of Bicara Therapeutics Common on the next trading day is expected to be 16.91 with a mean absolute deviation of 0.87 and the sum of the absolute errors of 46.21. Bicara Therapeutics after-hype prediction price | USD 17.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bicara Therapeutics to cross-verify your projections. Bicara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Bicara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bicara using various technical indicators. When you analyze Bicara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bicara Therapeutics 8 Period Moving Average Price Forecast For the 14th of January 2026
Given 90 days horizon, the 8 Period Moving Average forecasted value of Bicara Therapeutics Common on the next trading day is expected to be 16.91 with a mean absolute deviation of 0.87, mean absolute percentage error of 1.30, and the sum of the absolute errors of 46.21.Please note that although there have been many attempts to predict Bicara Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bicara Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bicara Therapeutics Stock Forecast Pattern
| Backtest Bicara Therapeutics | Bicara Therapeutics Price Prediction | Buy or Sell Advice |
Bicara Therapeutics Forecasted Value
In the context of forecasting Bicara Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bicara Therapeutics' downside and upside margins for the forecasting period are 12.87 and 20.96, respectively. We have considered Bicara Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Bicara Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Bicara Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.6694 |
| Bias | Arithmetic mean of the errors | -0.0157 |
| MAD | Mean absolute deviation | 0.8719 |
| MAPE | Mean absolute percentage error | 0.0519 |
| SAE | Sum of the absolute errors | 46.2113 |
Predictive Modules for Bicara Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bicara Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Bicara Therapeutics
For every potential investor in Bicara, whether a beginner or expert, Bicara Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bicara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bicara. Basic forecasting techniques help filter out the noise by identifying Bicara Therapeutics' price trends.Bicara Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicara Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicara Therapeutics could also be used in its relative valuation, which is a method of valuing Bicara Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bicara Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bicara Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bicara Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bicara Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bicara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bicara Therapeutics shares will generate the highest return on investment. By undertsting and applying Bicara Therapeutics stock market strength indicators, traders can identify Bicara Therapeutics Common entry and exit signals to maximize returns.
| Accumulation Distribution | 17209.66 | |||
| Daily Balance Of Power | 0.0926 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 17.07 | |||
| Day Typical Price | 17.22 | |||
| Price Action Indicator | 0.51 | |||
| Period Momentum Indicator | 0.1 |
Bicara Therapeutics Risk Indicators
The analysis of Bicara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bicara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bicara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.17 | |||
| Standard Deviation | 4.04 | |||
| Variance | 16.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bicara Stock Analysis
When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.